Reducing intravenous vancomycin use and cost savings – Full Text
"A stepwise incorporation of interventions, including education, the development of a novel exit-site scoring tool, and a treatment-based algorithm, resulted in a 78% decrease in IV vancomycin use in our pediatric chronic HD unit within 1 year and an 82% decrease in associated costs" Goswami and Pottanat (2026).